Aim: To assess the epistatic relationships of nitric oxide (NO) biosynthesis pathway genes in susceptibility to coronary heart disease (CHD). Methods: A total of 2142 subjects enrolled in two case-control studies was genotyped for 7 single-nucleotide polymorphisms (SNP) within NO biosynthesis pathway genes using TaqMan assays. The association analyses were performed at both SNP and haplotype levels. Two-way SNP-SNP interactions and high-order interactions were tested using multiple unconditional logistic regression analyses and generalized multifactor dimensionality reduction (GMDR) analyses, respectively. Results: Two alleles (rs1049255*C and rs841*A) were identified that were significantly associated with increased risk of CHD after adjusting for all confounders (OR=1.21, 95% CI: 1.06-1.39, combined P=0.001, P(corr)= 0.007 and OR=1.30, 95% CI 1.12-1.50, combined P<0.001, P(corr)< 0.001, respectively). Significant two-way SNP-SNP interactions were found between SNP rs2297518 and these two significant polymorphisms, affecting the risk of CHD (P<0.001 for both). No significant high-order interactions were identified. Conclusion: The results suggested that two-way SNP-SNP interactions of polymorphisms within NO biosynthesis pathway genes contribute to CHD risk.
基金:
National Natural Science Foundation of China [30430320]; National "863" project [2006AA02A406]; "973" project [2007CB512004]
第一作者单位:[1]Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan 430030, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
Tu Yuan-chao,Ding Hu,Wang Xiao-jing,et al.Exploring epistatic relationships of NO biosynthesis pathway genes in susceptibility to CHD[J].ACTA PHARMACOLOGICA SINICA.2010,31(7):874-880.doi:10.1038/aps.2010.68.
APA:
Tu, Yuan-chao,Ding, Hu,Wang, Xiao-jing,Xu, Yu-jun,Zhang, Lan...&Wang, Dao-wen.(2010).Exploring epistatic relationships of NO biosynthesis pathway genes in susceptibility to CHD.ACTA PHARMACOLOGICA SINICA,31,(7)
MLA:
Tu, Yuan-chao,et al."Exploring epistatic relationships of NO biosynthesis pathway genes in susceptibility to CHD".ACTA PHARMACOLOGICA SINICA 31..7(2010):874-880